Company
United StatesPublic company, NASDAQ: SNOASonoma Pharmaceuticals, Inc (NASDAQ: SNOA), Boulder, CO – FDA Inspections
Inspection records and compliance data for Sonoma Pharmaceuticals, Inc in Boulder, CO. 3 FDA inspections on record, last inspected November 02, 2016. Publicly traded as NASDAQ: SNOA.
Company Profile
This profile covers Sonoma Pharmaceuticals, Inc based in Boulder, CO, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected March 23, 2010. Last inspected November 2, 2016.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 2, 2016 | NAI | Medical Devices & Rad Health · Compliance: Devices | 994257 |
| September 13, 2011 | VAI | Human Drugs · Drug Quality Assurance | 743655 |
| March 23, 2010 | NAI | Medical Devices & Rad Health · Compliance: Devices | 655498 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Sonoma Pharmaceuticals, Inc
Stock ticker
SNOA
Exchange
NASDAQ
Share price
$1.08
Market cap
$5.2M
Price as of
November 6, 2026
FEI Number
3004554409
Address
5445 Conestoga Ct Ste 150, Boulder, CO 80301-3119, United States
Country
United States
ID: 86391617-0f66-4761-b5ca-22d6ed2b4a0f